Robert Zerbib
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 11
- Immune Cell Function and Interaction 10
- Oncology 10
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 5
- Cancer Treatment and Pharmacology 2
- Co-authors
- Pascale André (12 shared papers)Éric Vivier (2 shared papers)Amir Horowitz (1 shared paper)Thorbald van Hall (1 shared paper)Dan Fu Ruan (1 shared paper)Sjoerd H. van der Burg (1 shared paper)Émilie Narni-Mancinelli (1 shared paper)H Laborit (4 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Blood (4 papers)Annals of Oncology (3 papers)Cancer Research (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- FranceUnited StatesNetherlands
In The Last Decade
Robert Zerbib
26 papers receiving 724 citations
Peers
Comparison fields: 5 of 59
- Immunology 477
- Oncology 440
- Hematology 128
- Otorhinolaryngology 23
- Biological Psychiatry 12
Countries citing papers authored by Robert Zerbib
This map shows the geographic impact of Robert Zerbib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Zerbib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Zerbib more than expected).
Fields of papers citing papers by Robert Zerbib
This network shows the impact of papers produced by Robert Zerbib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Zerbib. The network helps show where Robert Zerbib may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Zerbib, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 207 | |
| 2 | 2015 | 148 | |
| 3 | 2018 | 111 | |
| 4 | 2011 | 43 | |
| 5 | Anxiolytic activity of melatonin in mice: involvement of benzodiazepine receptors. | 1993 | 38 |
| 6 | 2020 | 32 | |
| 7 | 2006 | 28 | |
| 8 | 2019 | 16 | |
| 9 | 2015 | 15 | |
| 10 | 2018 | 15 | |
| 11 | 2019 | 14 | |
| 12 | 1990 | 14 | |
| 13 | 2020 | 12 | |
| 14 | 2018 | 10 | |
| 15 | 2013 | 6 | |
| 16 | Role of various second messengers in the memorization of a passive or active avoidance | 1987 | 5 |
| 17 | 2013 | 3 | |
| 18 | 2013 | 3 | |
| 19 | 2017 | 2 | |
| 20 | 2025 | 2 |
About Robert Zerbib
Robert Zerbib is a scholar working on Immunology, Oncology, Hematology, Molecular Biology and Infectious Diseases, having authored 26 papers that have together received 734 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (10 papers), Cancer Immunotherapy and Biomarkers (7 papers), Multiple Myeloma Research and Treatments (6 papers), CAR-T cell therapy research (5 papers), COVID-19 Clinical Research Studies (3 papers), Glycosylation and Glycoproteins Research (2 papers), Hematopoietic Stem Cell Transplantation (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Immunology (477 citations), Oncology (440 citations), Hematology (128 citations), Otorhinolaryngology (23 citations) and Biological Psychiatry (12 citations). Robert Zerbib has collaborated with scholars based in France, United States and Netherlands. Frequent co-authors include Pascale André, Éric Vivier, Amir Horowitz, Thorbald van Hall, Dan Fu Ruan, Sjoerd H. van der Burg, Émilie Narni-Mancinelli, H Laborit, Don M. Benson and Yvonne A. Efebera. Their work appears in journals such as Journal of Clinical Oncology, Blood, Annals of Oncology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.